Volume 73, Issue 5 pp. 493-497
Full Access

Clinical study of 12 pathologically proven cases

The authors wish to thank Mrs Masnou for typing the manuscript.

G. Izquierdo

G. Izquierdo

Laboratoire de Neuropathologie Raymond Escourolle

Search for more papers by this author
O. Lyon-Caen

Corresponding Author

O. Lyon-Caen

Clinique de Neurologie et de Neuropsychologie, Hôpital de La Salpêtrière, Paris, France

Dr O. Lyon-Caen Clinique de Neurologie et de Neuropsychologie Hôpital de La Salpêtrière 47 Boulevard de I'Hôpital 75013 Paris FranceSearch for more papers by this author
R. Marteau

R. Marteau

Clinique de Neurologie et de Neuropsychologie, Hôpital de La Salpêtrière, Paris, France

Search for more papers by this author
Martinez-Parra

Martinez-Parra

Servicio de Neurologia, Hospital Universitario, Sevilla, Spain

Search for more papers by this author
F. Lhermitte

F. Lhermitte

Clinique de Neurologie et de Neuropsychologie, Hôpital de La Salpêtrière, Paris, France

Search for more papers by this author
P. Castaigne

P. Castaigne

Cliinque des Maladies du Système Nerveux, Hôpital de La Salpêtrière, Paris, France

Search for more papers by this author
J. J. Hauw

J. J. Hauw

Laboratoire de Neuropathologie Raymond Escourolle

Search for more papers by this author
First published: May 1986
Citations: 9

Abstract

ABSTRACT Among 70 pathologically proven MS cases, we found 12 cases with onset before 25. Only females were affected. There was no positive familial history of MS. In every case the diagnosis was considered during life. Mean duration of the disease was 29.1 ± 12.5 years. This was significantly longer (p < 0.001) than in the control group (58 pathologically proven cases with onset after 25). There were no acute courses. Progressive courses (1 case) and remittent courses (5 cases) were less frequent than in the control group (p < 0.001 and p < 0.01, respectively). The frequency of remittent-progressive courses (6 cases) was similar in both groups. The length of remittent-progressive courses (30.2 ± 16.2) and remittent courses (28.6 ± 9.7) was longer than that of control group (p < 0.001). The symptomatology of onset was similar in both groups and had no predictive value for prognosis. The overall frequency of signs and symptoms was not statistically different in both groups. For each sign, the percentage of affected patients, throughout the course of the disease, was always smaller in early onset MS than in control group, except for optic neuritis which was as frequent in both groups. However, this was statistically significant only for ocular motricity and nystagmus.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.